Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Na Lu"'
Autor:
J Antonio Aviña-Zubieta, Hui Xie, Yi Qian, John M. Esdaile, Diane Lacaille, Na Lu, Donald S. Garbuz, Vivienne Y Zhou, Jacek A. Kopec
Publikováno v:
Rheumatology. 61:1819-1830
Objectives To determine whether the introduction of biological DMARDs (bDMARDs) was associated with reduced incidences of total hip and knee arthroplasty (THA/TKA) among patients with RA compared with OA. Methods Using a population-based cohort in Br
Publikováno v:
Arthritis Care & Research. 73:259-265
OBJECTIVE Hip fractures have serious consequences, including a 1-year mortality rate of 30%. Population-based studies on hip fractures in individuals with systemic lupus erythematosus (SLE) are scarce. Our objective was to assess the independent risk
Publikováno v:
International Journal of Medical Sciences
Objective: To evaluate the characteristics at admission of patients with moderate COVID-19 in Wuhan and to explore risk factors associated with the severe prognosis of the disease for prognostic prediction. Methods: In this retrospective study, moder
Publikováno v:
Arthritis Care & Research. 72:1678-1686
Objective To identify 24-hour activity-sleep profiles in adults with arthritis and explore factors associated with profile membership. Methods Our study comprised a cross-sectional cohort and used baseline data from 2 randomized trials studying activ
Autor:
Kun Huang, Hyon K. Choi, Na Lu, John M. Esdaile, Kristin M. D’Silva, J Antonio Aviña-Zubieta, L. Li
Publikováno v:
Seminars in Arthritis and Rheumatism. 50:834-839
Objective To evaluate mortality trends in polymyositis (PM) and dermatomyositis (DM) between January 1, 1997, and December 31, 2014. Methods Using an administrative health database from the province of British Columbia, Canada, we identified all pati
Autor:
J Antonio Aviña-Zubieta, John M. Esdaile, Yufei Zheng, Na Lu, April Jorge, Mary A. De Vera, Hyon K. Choi, Natalie McCormick
Publikováno v:
Arthritis Care Res (Hoboken)
Objective Hydroxychloroquine (HCQ) has been associated with improved survival among patients with systemic lupus erythematosus (SLE) from tertiary referral centers. We aimed to determine the potential impact of HCQ use on the risk of mortality among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86fdc754a48b3dbaafb2ab889018eb0
https://europepmc.org/articles/PMC7665987/
https://europepmc.org/articles/PMC7665987/
Publikováno v:
Arthritis & Rheumatology. 71:403-410
OBJECTIVE A prior study showed that premature mortality among patients with end-stage renal disease (ESRD) due to lupus nephritis (LN) persisted in the US between 1995 and 2006. The present study was undertaken to extend this analysis through 2014 to
Publikováno v:
Seminars in Arthritis and Rheumatism. 48:449-455
Objectives Gout is associated with a higher risk of cardiovascular disease and premature mortality. We examined the potential survival benefit of statin use among gout patients in the general population. Methods We performed an incident user cohort s
Publikováno v:
The Journal of Rheumatology. 45:1689-1695
Objective.Systemic autoimmune rheumatic diseases (SARD) are associated with an increased risk of premature cardiovascular disease (CVD) and all-cause mortality. We examined the potential survival benefit of statin use among patients with SARD in a ge
Autor:
J Antonio Aviña-Zubieta, Na Lu, Yufei Zheng, Ana Michelle Avina-Galindo, L. Li, Diane Lacaille, Hyon K. Choi, John M. Esdaile
Publikováno v:
Rheumatology (Oxford)
Objectives To estimate the overall risk of venous thromboembolism (VTE), pulmonary embolism (PE) and deep vein thrombosis (DVT) among patients newly diagnosed with RA compared with the general population without RA; and to estimate the risk trends of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a3d3f19c73efe6328e4371af17b32bc
https://europepmc.org/articles/PMC7785304/
https://europepmc.org/articles/PMC7785304/